Canada Research Continuity Emergency Fund

OVERVIEW
The
Canada Research Continuity Emergency Fund (CRCEF), is part of the federal government's COVID-19 Economic Response Plan. The temporary program was established to help sustain research enterprises at Canadian universities and health research institutions affected by the COVID-19 pandemic. The program has 3 funding stages, the first of which  was to avert or reverse layoffs of eligible research personnel (e.g., research staff, students, post-doctoral fellows) paid in part or in whole by non-governmental sources. 

Details on Stage 3 are now available below. A new stage - Stage 4 - was recently announced by government. When details on Stage 4 are received, they will be added here. 

STAGE 3 - RESEARCH MAINTENANCE/RAMP-UP COSTS 
CRCEF Stage 3 is to support direct costs of research that have been incurred to:

  • Maintain essential research-related commitments during COVID-19; and
  • Support the ramp up to full research activities as physical distancing measures are eased and research activities can resume.

ELIGIBILITY
Only extraordinary and incremental direct costs of research related to those already covered by existing sources of funds are eligible, and only for the time period March 15 - Nov 15, 2020. Eligible expenses will be reimbursed up to 75%. Funding will be provided to faculties based on its relative share of total research revenue in fiscal 2020. Research Services informed faculties of their respective allocations. 

FACULTY ALLOCATION

Each faculty receiving an allocation for Stage 3 will need to develop a process by which their Project Holders with eligible costs can submit requests to their faculty office for review and approval.  The process should consider a faculty’s unique needs along with those of its departments and researchers. 

Faculties will be responsible for ensuring that approved expenses are eligible for CRCEF stage 3 relief and that they do not exceed their allocation. 

REPORTING REQUIREMENTS

The university must report its total institutional Stage 3 funding need to the CRCEF program by December 15, 2020 or risk losing its allocation.  To accommodate this, all eligible and approved costs must be submitted to the Office of the VP(RI) no later than December 11, 2020 for processing.  Any costs received after this date will not be reimbursed.  Additional details about these requirements have been provided to the faculty contacts. 

STAGE 2 - DOESN'T APPLY TO UALBERTA 

STAGE 1 - CLOSED

  • Approved UAlberta applications are now being processed. 
  • UAlberta affiliated health research institution Alberta Health Services (AHS), received Stage 1 fundingUAlberta distributed Stage 1 funds to AHS based upon the proportionate share of non-governmental research revenues earned by AHS and UAlberta.   
UALBERTA CRCEF EDI STRATEGY
The University of Alberta envisions and cultivates a community where equity and diversity are fundamental to inclusive excellence in learning, teaching, research, service, and community engagement--as stated in our
Equity, Diversity, and Inclusivity (EDI) Strategic Plan and as pledged as a Dimensions Charter signatory.  


The university’s CRCEF Governance and Review Committee is composed of personnel from our
Vice-President (Research and Innovation) Office, Research Services, Human Resources and several members of different equity-seeking groups (Indigenous, Black and people of color, people with disabilities, LGBTQ+, women). This committee will decide how CRCEF funds will be allocated and adhere to the university's commitment to a diverse, inclusive community of exceptional students, faculty, and staff from Alberta, Canada, and the world. Committee members have completed the Tricouncil’s Unconscious Bias Training Module and the Government of Canada’s Introduction to Gender-Based Analysis+ course. 

OFFICIALS RESPONSIBLE FOR UALBERTA CRCEF PROGRAM

  • Primary contact: Michael Walesiak, Director, Finance & Administration
    Office of the Vice-President (Research and Innovation)
    780.492.1642 | walesiak@ualberta.ca
  • Vice-president responsible: Walter T. Dixon, Interim Vice-President (Research and Innovation)